{"id":"https://openalex.org/W3003168334","doi":null,"title":"THE PPAR gamma AGONIST PIOGLITAZONE UPREGULATES EAAT2 EXPRESSION IN HUMAN GLIOBLASTOMA CELLS","display_name":"THE PPAR gamma AGONIST PIOGLITAZONE UPREGULATES EAAT2 EXPRESSION IN HUMAN GLIOBLASTOMA CELLS","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W3003168334","mag":"3003168334"},"language":"en","primary_location":{"id":"mag:3003168334","doi":null,"is_oa":false,"landing_page_url":"https://findanexpert.unimelb.edu.au/scholarlywork/1397635-the-ppar-gamma-agonist-pioglitazone-upregulates-eaat2-expression-in-human-glioblastoma-cells","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Neuro-Oncology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042750148","display_name":"Jared Ching","orcid":"https://orcid.org/0000-0002-3562-8055","observed_orcids":["https://orcid.org/0000-0002-3562-8055","https://orcid.org/0000-0002-8128-293X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jared Ching","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3562-8055","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043423822","display_name":"Stephanie Amiridis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie Amiridis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108468010","display_name":"Andrew R. Bjorksten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew R. Bjorksten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043854973","display_name":"Thomas W. Zheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Zheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060906848","display_name":"Stanley S. Stylli","orcid":"https://orcid.org/0000-0002-3505-7387","observed_orcids":["https://orcid.org/0000-0002-3505-7387"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley S. Stylli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3505-7387","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029827265","display_name":"Andrew P. Morokoff","orcid":"https://orcid.org/0000-0002-5159-3438","observed_orcids":["https://orcid.org/0000-0002-5159-3438"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Morokoff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5159-3438","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103716571","display_name":"Terence O'Brien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terence O'Brien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054088397","display_name":"Andrew H. Kaye","orcid":"https://orcid.org/0000-0001-5049-8861","observed_orcids":["https://orcid.org/0000-0001-5049-8861"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew H. Kaye","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5049-8861","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.39604549,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.1080000028014183,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9020000100135803},{"id":"https://openalex.org/keywords/glt-1","display_name":"GLT-1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/glutamate-transporters","display_name":"glutamate transporters","score":0.7749999761581421},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/gene-upregulation","display_name":"gene upregulation","score":0.8960000276565552},{"id":"https://openalex.org/keywords/human-glioblastoma-cells","display_name":"human glioblastoma cells","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9866347908973694},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.7376342415809631},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7196813821792603},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.613274335861206},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.5629753470420837},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48398613929748535},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4175738990306854},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4143671691417694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40159499645233154},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35473406314849854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2726028561592102},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.09048342704772949},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3003168334","doi":null,"is_oa":false,"landing_page_url":"https://findanexpert.unimelb.edu.au/scholarlywork/1397635-the-ppar-gamma-agonist-pioglitazone-upregulates-eaat2-expression-in-human-glioblastoma-cells","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Neuro-Oncology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318343467","https://openalex.org/W7217070859","https://openalex.org/W4235243489","https://openalex.org/W2111745312","https://openalex.org/W2019685247","https://openalex.org/W2083314308","https://openalex.org/W2076455660","https://openalex.org/W4256215161","https://openalex.org/W2356816584","https://openalex.org/W1986712005"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-02-07T00:00:00"}